|
2011 CABA Investment, Innovation & Entrepreneurship Symposium (Oct. 8th) 美中生物医药协会二〇一一投资,创新与创业研讨会 "Pharma Open Innovations: Opportunities for Investors and Entrepreneurs" Presented by: Chinese-American BioMedical Association (CABA) When: 1:00PM-9:00PM, Saturday, October 8, 2011 Where: The Doubletree Guest Suites, Boston MA, 400 Soldiers Field Road, Boston, MA 02134 Speakers: Luke Li, Ph.D., Exec Director, Head of Global Biotherapeutic Technologies, Bio-Innovation, Pfizer Sridaran Natesan, Ph.D., Scientific Site Head (R&D) at Sanofi-Aventis Cambridge and Head of External Innovation and Partnering for the US Northeast region David Dalgarno, Ph.D., VP of Research Technologies, Ariad Wei Li, Ph.D., Principal, Fidelity Bioscience Ventures Gayathri Srinivasan, Ph.D., Licensing Officer, University of Massachusetts Medical School Karen Wong, Partner, Wilson Sonsini Goodrich & Rosati LLP Jean Qiu, Ph.D., Founder & CTO, Nexcelom Bioscience
"Simcere Night先声之夜" 6:30PM - 9:00PM Evening Keynote: Peng Wang, Ph.D., CSO, Simcere Pharmaceutical Group (先声药业) Admission: CABA, CAIPLA, OCEAN, ACMA, NECINA, 128CUTE members: FREE; Non-members: $20. On-site membership registration to CABA available. ($20 annual membership fee due), you can also register online at www.cabaweb.org. Parking Direction: Please enter the hotel parking garage from Storrow Drive. Parking is free. Contacts: Philip Zhang, Ph.D., J.D., philip.zhang@mzwiplaw.com Jinbo Lee, Ph.D., jk.lee@sage-partner.com Zhihong Chen, Ph.D., zhihongchen06@yahoo.com |
|
|